Neurologic Imaging

ACR Workflow: What Is the Best Initial Imaging for a Nonpulsatile Neck Mass?

·
ACR Workflow: What Is the Best Initial Imaging for a Nonpulsatile Neck Mass?

A 58-year-old male with a significant smoking history presents to your clinic with a new, firm, painless 3 cm mass in the left neck at level II. It is nonpulsatile on physical examination. You suspect a metastatic lymph node from an unknown primary squamous cell carcinoma, but lymphoma or a benign process also remain on the differential. The immediate next step is imaging, but which modality provides the most diagnostic information to guide management? This article details the American College of Radiology (ACR) Appropriateness Criteria for this exact clinical question. For the initial imaging of a nonpulsatile neck mass located outside the parotid or thyroid glands, `MRI neck without and with IV contrast` is rated Usually appropriate.

Who Fits This Clinical Scenario for a Nonpulsatile Neck Mass?

This guidance applies to adult patients presenting for initial imaging of one or more neck masses that are nonpulsatile on physical examination. The key is the absence of a palpable thrill or an audible bruit, which would suggest a primary vascular lesion or a highly vascular tumor. This workflow is specifically tailored for masses that do not appear to originate from the parotid gland (typically in the preauricular or retromandibular region) or the thyroid gland (midline, moving with swallowing), as those locations have distinct diagnostic pathways.

It is critical to distinguish this presentation from similar but distinct clinical scenarios that follow different ACR guidelines:

  • Pulsatile Neck Mass: If the mass has a palpable thrill or an audible bruit, the differential shifts significantly toward vascular etiologies like a carotid body tumor, aneurysm, or arteriovenous fistula. This requires a dedicated vascular imaging workup.
  • Parotid Region Mass: A mass clearly located within the substance of the parotid gland requires a workup focused on salivary gland pathology, which has its own imaging algorithm.
  • Pediatric Neck Mass: The differential diagnosis and considerations regarding radiation exposure are substantially different in children, where congenital and inflammatory causes are more common than malignancy.

What Diagnoses Are You Working Up in This Scenario?

For a new, nonpulsatile neck mass in an adult, the imaging workup is primarily driven by the need to differentiate between malignant, inflammatory, and congenital causes. The differential diagnosis guides the choice of imaging modality.

Metastatic Malignancy is the foremost concern, especially in patients over 40 with risk factors like smoking or alcohol use. The most common culprit is metastatic squamous cell carcinoma (SCC) from an undiscovered primary tumor in the upper aerodigestive tract. Imaging is crucial for identifying suspicious nodal features (e.g., central necrosis, irregular borders, extracapsular extension) and surveying potential primary sites in the nasopharynx, oropharynx, larynx, and hypopharynx.

Lymphoma frequently presents as painless, rubbery cervical lymphadenopathy. Both Hodgkin and non-Hodgkin lymphoma are common causes. Imaging helps characterize the extent of nodal involvement, assess for nodal conglomeration, and identify disease in other sites, which is essential for staging and guiding biopsy.

Infectious or Inflammatory Adenopathy can also present as a neck mass, though it is often accompanied by pain, tenderness, or systemic symptoms. Causes range from bacterial infections (like suppurative adenitis leading to an abscess) to viral etiologies (e.g., infectious mononucleosis) or granulomatous diseases like tuberculosis (scrofula) or sarcoidosis. Imaging can identify features like abscess formation that require urgent drainage.

Benign Tumors and Congenital Cysts are less common but important considerations. These include nerve sheath tumors like schwannomas, which arise from the vagus nerve or cervical sympathetic chain. Congenital lesions, such as a branchial cleft cyst (typically lateral at level II/III) or a thyroglossal duct cyst (midline), can present for the first time in adulthood, often after becoming infected.

Why Is MRI Neck Without and With IV Contrast the Recommended Study?

The ACR designates `MRI neck without and with IV contrast` as Usually appropriate for this scenario due to its superior soft-tissue contrast resolution and lack of ionizing radiation. This makes it exceptionally well-suited for characterizing the internal architecture of a mass and its relationship to adjacent structures.

MRI excels at differentiating cystic from solid components, identifying perineural tumor spread, and evaluating the deep spaces of the neck, including the mucosal surfaces of the pharynx and larynx where a primary SCC may be hiding. The addition of intravenous contrast is critical; it highlights enhancement patterns that help distinguish benign from malignant lesions, identify nodal necrosis (a key sign of metastatic SCC), and delineate abscess walls. For these reasons, `MRI neck without IV contrast` is only rated May be appropriate, as it lacks the crucial diagnostic information provided by gadolinium.

While `CT neck with IV contrast` is also rated Usually appropriate, it is often considered the second-best option for initial characterization. CT is faster and more widely available, but it delivers a moderate radiation dose (☢☢☢ 1-10 mSv) and provides less soft-tissue detail compared to MRI. It is an excellent alternative when MRI is contraindicated (e.g., incompatible metallic implants, severe claustrophobia) or when bony erosion is a primary concern. `CT neck without IV contrast` is only rated May be appropriate, as it fails to characterize vascularity and can miss enhancing primary tumors or nodal disease.

Finally, `US neck` is rated May be appropriate. Ultrasound is a valuable, non-invasive tool for initial assessment, especially in a younger patient or when the mass is superficial. It can confirm if a mass is cystic or solid and can guide fine-needle aspiration (FNA). However, its utility is limited by operator dependence and its inability to visualize deep structures of the neck or the mucosal primary sites, making it insufficient as a standalone comprehensive study for suspected malignancy.

What’s Next After MRI? Downstream Workflow

The results of the contrast-enhanced neck MRI will dictate the subsequent clinical pathway. The goal is to obtain a tissue diagnosis and, if malignant, to identify the primary source.

If the MRI suggests metastatic carcinoma (e.g., a necrotic lymph node): The next step is typically a referral to an Otolaryngologist (ENT) for a comprehensive head and neck examination, including panendoscopy under anesthesia. This procedure involves direct visualization of the nasopharynx, oropharynx, larynx, and hypopharynx to search for a primary tumor. An ultrasound-guided fine-needle aspiration (FNA) or core needle biopsy of the neck mass is performed to confirm the pathologic diagnosis.

If the MRI findings are suspicious for lymphoma: The diagnostic pathway shifts toward obtaining a larger tissue sample, as FNA is often insufficient for lymphoma subtyping. An excisional or core needle biopsy of an involved lymph node is required for definitive histologic and immunophenotypic analysis. A Hematology/Oncology consultation is warranted.

If the MRI is negative or shows only benign-appearing reactive nodes: If clinical suspicion remains low, a period of observation with a follow-up examination in 4-6 weeks may be appropriate. If the mass persists or grows, or if clinical suspicion is high despite the negative imaging, proceeding to FNA or biopsy is still a reasonable step to rule out an occult process.

If the MRI reveals a specific benign entity (e.g., a classic branchial cleft cyst): Management may involve surgical excision if the mass is symptomatic or for definitive diagnosis, or observation if it is small and asymptomatic.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup of a nonpulsatile neck mass requires careful attention to detail to avoid common diagnostic errors.

  • Omitting IV Contrast: Ordering a non-contrast CT or MRI for a neck mass evaluation is a frequent pitfall. Contrast is essential for characterizing the lesion, assessing for necrosis, and identifying a potential primary tumor.
  • Mischaracterizing the Mass: Failing to perform a careful physical exam to assess for a bruit or thrill can lead to ordering the wrong initial study. A pulsatile mass requires a vascular-focused protocol (CTA or MRA), not a standard soft-tissue neck study.
  • Ignoring Patient Demographics: The differential diagnosis is heavily influenced by age and risk factors. A new neck mass in an older smoker should be considered malignant until proven otherwise, warranting an expedited and thorough workup.
  • Inadequate Biopsy: Relying solely on FNA for a suspected lymphoma can lead to a non-diagnostic sample. If lymphoma is high on the differential, an excisional or core biopsy is almost always necessary.

If you encounter imaging findings suggestive of deep space infection with abscess, vascular invasion, or airway compromise, escalate immediately with an urgent ENT or surgical consultation.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to neck masses and adenopathy, please see our parent guide. For further exploration of imaging guidelines, protocols, and radiation safety, the following resources are available:

Frequently Asked Questions

Why is MRI preferred over CT if both are ‘Usually appropriate’ for a nonpulsatile neck mass?

MRI is generally preferred because it offers superior soft-tissue contrast without using ionizing radiation. This allows for better characterization of the mass itself and its relationship with adjacent muscles, nerves, and vessels. It is particularly effective at identifying subtle mucosal primary tumors. CT is an excellent alternative if MRI is contraindicated or unavailable.

Is an ultrasound enough for the initial workup of a nonpulsatile neck mass?

While ultrasound is rated ‘May be appropriate,’ it is typically not sufficient as a standalone study for a comprehensive workup, especially if malignancy is suspected. It is excellent for guiding a biopsy and determining if a mass is cystic or solid, but it cannot adequately visualize the deep structures of the neck or potential primary tumor sites in the pharynx and larynx. It is often used as an adjunct to MRI or CT.

What if the patient has a contraindication to MRI, like a pacemaker?

If a patient has a contraindication to MRI, ‘CT neck with IV contrast’ is the best alternative. It is also rated ‘Usually appropriate’ by the ACR and provides excellent information regarding lymph node characteristics, deep space involvement, and potential primary tumors, though with less soft-tissue detail than MRI.

Do I need to order a PET/CT for the initial workup of a neck mass?

No, a PET/CT is rated ‘Usually not appropriate’ for the *initial* imaging of a neck mass. Its role is in staging a *known* malignancy, searching for an unknown primary after a diagnosis of metastatic carcinoma is confirmed via biopsy, or assessing for treatment response. It is not a first-line diagnostic tool for an undifferentiated mass.

The scenario excludes thyroid and parotid masses. What if I’m not sure where the mass is coming from?

If the origin of the mass is ambiguous on physical exam, a contrast-enhanced MRI or CT of the neck is still the correct initial step. These cross-sectional modalities will precisely localize the mass and determine if it arises from the thyroid, parotid, a lymph node, or another structure, thereby guiding the subsequent diagnostic pathway.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026